{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:01:05Z","timestamp":1791482465521,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":2566,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1074\/jbc.m113.463562","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T16:38:14Z","timestamp":1374683894000},"page":"26052-26066","source":"Crossref","is-referenced-by-count":80,"title":["\u03b2-Glucosidase 2 (GBA2) Activity and Imino Sugar Pharmacology"],"prefix":"10.1016","volume":"288","author":[{"given":"Christina M.","family":"Ridley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Thur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Shanahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendra Babu","family":"Thillaiappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karly","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Walden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad A.","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon N.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarnoud C.","family":"van der Spoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.463562_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1098\/rstb.2003.1266","article-title":"The fate and function of glycosphingolipid glucosylceramide","volume":"358","author":"van Meer","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci"},{"key":"10.1074\/jbc.M113.463562_bib2","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.91.7.2708","article-title":"Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway","volume":"91","author":"Warnock","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.463562_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature06097","article-title":"Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide","volume":"449","author":"D'Angelo","year":"2007","journal-title":"Nature"},{"key":"10.1074\/jbc.M113.463562_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200704091","article-title":"Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis","volume":"179","author":"Halter","year":"2007","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M113.463562_bib5","doi-asserted-by":"crossref","first-page":"25859","DOI":"10.1074\/jbc.R200001200","article-title":"Combinatorial ganglioside biosynthesis","volume":"277","author":"Kolter","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib6","series-title":"Glycolipids: Animal, eLS","author":"Hakomori","year":"2006"},{"key":"10.1074\/jbc.M113.463562_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.cellbio.21.122303.120013","article-title":"Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids","volume":"21","author":"Kolter","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol"},{"key":"10.1074\/jbc.M113.463562_bib8","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1074\/jbc.M610544200","article-title":"Identification of the non-lysosomal glucosylceramidase as \u03b2-glucosidase 2","volume":"282","author":"Boot","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib9","doi-asserted-by":"crossref","first-page":"32655","DOI":"10.1074\/jbc.M702387200","article-title":"Accumulation of glucosylceramide in murine testis, caused by inhibition of \u03b2-glucosidase 2: implications for spermatogenesis","volume":"282","author":"Walden","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib10","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of \u03b2-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M113.463562_bib11","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1074\/jbc.M112.414714","article-title":"The non-lysosomal \u03b2-glucosidase GBA2 is a non-integral membrane-associated protein at the endoplasmic reticulum (ER) and Golgi","volume":"288","author":"K\u00f6rschen","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib12","series-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Grabowski","year":"2000"},{"key":"10.1074\/jbc.M113.463562_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","article-title":"Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia","volume":"92","author":"Martin","year":"2013","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.M113.463562_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajhg.2012.12.012","article-title":"Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity","volume":"92","author":"Hammer","year":"2013","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.M113.463562_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1096\/fj.12-215152","article-title":"The nonlysosomal \u03b2-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells","volume":"27","author":"Sorli","year":"2013","journal-title":"FASEB J"},{"key":"10.1074\/jbc.M113.463562_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/187152012800228661","article-title":"Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death","volume":"12","author":"Mullen","year":"2012","journal-title":"Anticancer Agents Med. Chem"},{"key":"10.1074\/jbc.M113.463562_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.chemphyslip.2012.02.006","article-title":"Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids","volume":"165","author":"Gatt","year":"2012","journal-title":"Chem. Phys. Lipids"},{"key":"10.1074\/jbc.M113.463562_bib18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2217\/fon.10.116","article-title":"Sphingolipids and cancer: ceramide and sphingosine 1-phosphate in the regulation of cell death and drug resistance","volume":"6","author":"Ponnusamy","year":"2010","journal-title":"Future Oncol"},{"key":"10.1074\/jbc.M113.463562_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/clp.11.71","article-title":"Ceramide as a target of chemotherapy: its role in apoptosis and autophagy","volume":"7","author":"Palma","year":"2012","journal-title":"Clin. Lipidol"},{"key":"10.1074\/jbc.M113.463562_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2174\/187152011797655131","article-title":"Regulation of autophagy by sphingolipids","volume":"11","author":"Bedia","year":"2011","journal-title":"Anticancer Agents Med. Chem"},{"key":"10.1074\/jbc.M113.463562_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2174\/187152011797655069","article-title":"Sphingolipid metabolism and drug resistance in hematological malignancies","volume":"11","author":"Gouaze-Andersson","year":"2011","journal-title":"Anticancer Agents Med. Chem"},{"key":"10.1074\/jbc.M113.463562_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/978-1-4419-6741-1_11","article-title":"Glucosylceramide in humans","volume":"688","author":"Messner","year":"2010","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1074\/jbc.M113.463562_bib23","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1039\/c1ob05119a","article-title":"Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain","volume":"9","author":"Ardes-Guisot","year":"2011","journal-title":"Org. Biomol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib24","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/jm201633y","article-title":"Rapid assembly of a library of lipophilic iminosugars via the thiol-ene reaction yields promising pharmacological chaperones for the treatment of Gaucher disease","volume":"55","author":"Goddard-Borger","year":"2012","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.463562_bib25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/jo061280p","article-title":"Development of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man","volume":"72","author":"Wennekes","year":"2007","journal-title":"J. Org. Chem"},{"key":"10.1074\/jbc.M113.463562_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/ml100192b","article-title":"Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars","volume":"2","author":"Ghisaidoobe","year":"2010","journal-title":"ACS Med. Chem. Lett"},{"key":"10.1074\/jbc.M113.463562_bib27","doi-asserted-by":"crossref","first-page":"12529","DOI":"10.1002\/anie.201207771","article-title":"Novel activity-based probes for broad-spectrum profiling of retaining \u03b2-exoglucosidases in situ and in vivo","volume":"51","author":"Kallemeijn","year":"2012","journal-title":"Angew. Chem. Int. Ed Engl"},{"key":"10.1074\/jbc.M113.463562_bib28","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1021\/jo202054g","article-title":"Synthesis and evaluation of eight- and four-membered iminosugar analogues as inhibitors of testicular ceramide-specific glucosyltransferase, testicular \u03b2-glucosidase 2, and other glycosidases","volume":"77","author":"Lee","year":"2012","journal-title":"J. Org. Chem"},{"key":"10.1074\/jbc.M113.463562_bib29","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1021\/jm300342q","article-title":"Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating Gaucher disease","volume":"55","author":"Trapero","year":"2012","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.463562_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"Platt","year":"2008","journal-title":"Acta Paediatr. Suppl"},{"key":"10.1074\/jbc.M113.463562_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ymgme.2010.03.019","article-title":"DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts","volume":"100","author":"Fantur","year":"2010","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.M113.463562_bib32","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M113.463562_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2008.12.017","article-title":"Molecular interaction of imino sugars with human \u03b1-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease","volume":"96","author":"Sugawara","year":"2009","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.M113.463562_bib34","doi-asserted-by":"crossref","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","article-title":"Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase","volume":"273","author":"Overkleeft","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib35","doi-asserted-by":"crossref","first-page":"11261","DOI":"10.1074\/jbc.272.17.11261","article-title":"Purification and characterization of a microsomal bile acid \u03b2-glucosidase from human liver","volume":"272","author":"Matern","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib36","doi-asserted-by":"crossref","first-page":"27108","DOI":"10.1016\/S0021-9258(18)47132-3","article-title":"N-Butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing","volume":"269","author":"Platt","year":"1994","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib37","doi-asserted-by":"crossref","first-page":"e21758","DOI":"10.1371\/journal.pone.0021758","article-title":"Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease","volume":"6","author":"Ashe","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M113.463562_bib38","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ymgme.2012.01.020","article-title":"Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice","volume":"105","author":"Nietupski","year":"2012","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.M113.463562_bib39","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.1074\/jbc.272.31.19365","article-title":"Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin","volume":"272","author":"Platt","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","article-title":"N-Butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo","volume":"59","author":"Andersson","year":"2000","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M113.463562_bib41","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/hep.23175","article-title":"Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice","volume":"50","author":"Bijl","year":"2009","journal-title":"Hepatology"},{"key":"10.1074\/jbc.M113.463562_bib42","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","article-title":"Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity","volume":"56","author":"Aerts","year":"2007","journal-title":"Diabetes"},{"key":"10.1074\/jbc.M113.463562_bib43","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","article-title":"Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin","volume":"96","author":"Jeyakumar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.463562_bib44","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2004.04.012","article-title":"Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease","volume":"16","author":"Andersson","year":"2004","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.M113.463562_bib45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.276.5311.428","article-title":"Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin","volume":"276","author":"Platt","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.M113.463562_bib46","doi-asserted-by":"crossref","first-page":"17173","DOI":"10.1073\/pnas.262586099","article-title":"Reversible infertility in male mice following oral administration of alkylated imino sugars: a non-hormonal approach to male contraception","volume":"99","author":"van der Spoel","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.463562_bib47","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/humrep\/dei463","article-title":"Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin","volume":"21","author":"Walden","year":"2006","journal-title":"Hum. Reprod"},{"key":"10.1074\/jbc.M113.463562_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-5-1","article-title":"The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study","volume":"5","author":"Bone","year":"2007","journal-title":"Reprod. Biol. Endocrinol"},{"key":"10.1074\/jbc.M113.463562_bib49","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/humrep\/del414","article-title":"Miglustat has no apparent effect on spermatogenesis in normal men","volume":"22","author":"Amory","year":"2007","journal-title":"Hum. Reprod"},{"key":"10.1074\/jbc.M113.463562_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2009.07.010","article-title":"Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1","volume":"36","author":"Smith","year":"2009","journal-title":"Neurobiol. Dis"},{"key":"10.1074\/jbc.M113.463562_bib51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/NEN.0b013e31825414a6","article-title":"Miglustat improves Purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C","volume":"71","author":"Stein","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1074\/jbc.M113.463562_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1185\/03007990802576518","article-title":"Goal-oriented therapy with miglustat in Gaucher disease","volume":"25","author":"Pastores","year":"2009","journal-title":"Curr. Med. Res. Opin"},{"key":"10.1074\/jbc.M113.463562_bib53","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1074\/jbc.M113.463562_bib54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2147\/TCRM.S5777","article-title":"New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat","volume":"5","author":"Wraith","year":"2009","journal-title":"Ther. Clin. Risk. Manag"},{"key":"10.1074\/jbc.M113.463562_bib55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0883073809344222","article-title":"Long-term miglustat therapy in children with Niemann-Pick disease type C","volume":"25","author":"Patterson","year":"2010","journal-title":"J. Child. Neurol"},{"key":"10.1074\/jbc.M113.463562_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4614-0650-1_7","article-title":"Glycosphingolipids and insulin resistance","volume":"721","author":"Aerts","year":"2011","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1074\/jbc.M113.463562_bib57","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4155\/fmc.11.117","article-title":"Iminosugars as therapeutic agents: recent advances and promising trends","volume":"3","author":"Nash","year":"2011","journal-title":"Future Med. Chem"},{"key":"10.1074\/jbc.M113.463562_bib58","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00018-008-8522-3","article-title":"Sugar-mimicking glycosidase inhibitors: bioactivity and application","volume":"66","author":"Asano","year":"2009","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1074\/jbc.M113.463562_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drudis.2010.08.017","article-title":"Iminosugars past, present and future: medicines for tomorrow","volume":"16","author":"Horne","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1074\/jbc.M113.463562_bib60","first-page":"S111","article-title":"Pharmacological chaperone therapy by active-site-specific chaperones in Fabry disease: in vitro and preclinical studies","volume":"47","author":"Germain","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther"},{"key":"10.1074\/jbc.M113.463562_bib61","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol. Med"},{"key":"10.1074\/jbc.M113.463562_bib62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0925-4439(93)90090-N","article-title":"Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease","volume":"1181","author":"van Weely","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.463562_bib63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0009-8981(81)90251-5","article-title":"An improved fluorometric leukocyte \u03b2-glucosidase assay for Gaucher's disease","volume":"115","author":"Daniels","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/jbc.M113.463562_bib64","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1471-4159.1976.tb05159.x","article-title":"Hydrolytic and transglucolytic activities of a partially purified calf brain \u03b2-glucosidase","volume":"27","author":"Mumford","year":"1976","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.463562_bib65","doi-asserted-by":"crossref","first-page":"23815","DOI":"10.1074\/jbc.M502799200","article-title":"X-ray structure of human acid-\u03b2-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease","volume":"280","author":"Premkumar","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib66","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.83.6.1660","article-title":"Human acid \u03b2-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site","volume":"83","author":"Dinur","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.463562_bib67","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1016\/S0021-9258(19)83905-4","article-title":"Human acid \u03b2-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes","volume":"261","author":"Grabowski","year":"1986","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib68","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.463562_bib69","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1073\/pnas.86.24.9896","article-title":"Salvage of glucosylceramide by recycling after internalization along the pathway of receptor-mediated endocytosis","volume":"86","author":"Kok","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.463562_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abio.1999.4202","article-title":"Fluorogenic substrates based on fluorinated umbelliferones for continuous assays of phosphatases and \u03b2-galactosidases","volume":"273","author":"Gee","year":"1999","journal-title":"Anal. Biochem"},{"key":"10.1074\/jbc.M113.463562_bib71","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1177\/1087057109336751","article-title":"Mechanism-based inhibition: deriving KI and kinact directly from time-dependent IC50 values","volume":"14","author":"Krippendorff","year":"2009","journal-title":"J. Biomol. Screen"},{"key":"10.1074\/jbc.M113.463562_bib72","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1203\/00006450-199602000-00021","article-title":"Turnover and distribution of intravenously administered mannose-terminated human acid \u03b2-glucosidase in murine and human tissues","volume":"39","author":"Xu","year":"1996","journal-title":"Pediatr. Res"},{"key":"10.1074\/jbc.M113.463562_bib73","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1073\/pnas.87.6.2334","article-title":"Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease","volume":"87","author":"Fink","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.463562_bib74","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J"},{"key":"10.1074\/jbc.M113.463562_bib75","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib76","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid \u03b2-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.463562_bib77","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0005-2744(77)90036-5","article-title":"Cell-specific differences in membrane \u03b2-glucosidase from normal and Gaucher cells","volume":"480","author":"Turner","year":"1977","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.463562_bib78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-0004.1978.tb04242.x","article-title":"Synthetic substrate \u03b2-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease","volume":"13","author":"Wenger","year":"1978","journal-title":"Clin. Genet"},{"key":"10.1074\/jbc.M113.463562_bib79","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcmd.2005.03.006","article-title":"Use of fluorescent substrates for characterization of Gaucher disease mutations","volume":"35","author":"Ron","year":"2005","journal-title":"Blood Cells Mol. Dis"},{"key":"10.1074\/jbc.M113.463562_bib80","series-title":"Enzymes: Irreversible Inhibition, eLS","author":"McDonald","year":"2012"},{"key":"10.1074\/jbc.M113.463562_bib81","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.M113.463562_bib82","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-4800(88)90068-8","article-title":"Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells","volume":"48","author":"Newburg","year":"1988","journal-title":"Exp. Mol. Pathol"},{"key":"10.1074\/jbc.M113.463562_bib83","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<365::AID-JNR11>3.0.CO;2-4","article-title":"In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology","volume":"43","author":"Prence","year":"1996","journal-title":"J. Neurosci. Res"},{"key":"10.1074\/jbc.M113.463562_bib84","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/jm901281m","article-title":"Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation","volume":"53","author":"Wennekes","year":"2010","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.463562_bib85","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10545-012-9478-x","article-title":"Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts","volume":"35","author":"Aureli","year":"2012","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.1074\/jbc.M113.463562_bib86","article-title":"Increased glucocerebrosidase (GBA) 2 activity in GBA1 deficient mice brains and in Gaucher leucocytes","author":"Burke","year":"2012","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.1074\/jbc.M113.463562_bib87","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol"},{"key":"10.1074\/jbc.M113.463562_bib88","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.463562_bib89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcmd.2004.03.001","article-title":"Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes","volume":"33","author":"Trajkovic-Bodennec","year":"2004","journal-title":"Blood Cells Mol. Dis"},{"key":"10.1074\/jbc.M113.463562_bib90","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymgme.2007.08.001","article-title":"Secondary sphingolipid accumulation in a macrophage model of Gaucher disease","volume":"92","author":"Hein","year":"2007","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.M113.463562_bib91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/mthe.2002.0650","article-title":"Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model","volume":"6","author":"Marshall","year":"2002","journal-title":"Mol. Ther"},{"key":"10.1074\/jbc.M113.463562_bib92","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1471-4159.1978.tb12395.x","article-title":"The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects","volume":"30","author":"Stephens","year":"1978","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M113.463562_bib93","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10545-006-0411-z","article-title":"Glucosylceramide transfer from lysosomes\u2013the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data","volume":"29","author":"Elleder","year":"2006","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.1074\/jbc.M113.463562_bib94","doi-asserted-by":"crossref","first-page":"D233","DOI":"10.1093\/nar\/gkn663","article-title":"The Carbohydrate-active EnZymes database (CAZy): an expert resource for Glycogenomics","volume":"37","author":"Cantarel","year":"2009","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820536016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820536016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.463562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:28:48Z","timestamp":1641342528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820536016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":94,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0021925820536016"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.463562","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}